We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

ReShape Lifesciences Inc (RSLS) USD0.001

Sell:$0.18 Buy:$0.19 Change: $0.0008 (0.44%)
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
Sell:$0.18
Buy:$0.19
Change: $0.0008 (0.44%)
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
Sell:$0.18
Buy:$0.19
Change: $0.0008 (0.44%)
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ReShape Lifesciences Inc. is a weight-loss solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease throughout the care continuum. Its portfolio includes Lap-Band system, which provides minimally invasive, long-term treatment of obesity and is a safer surgical alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. Its ReShapeCare virtual health coaching program is a weight-management program that supports healthy lifestyle changes for all medically managed weight-loss patients. Its ReShapeMarketplace online store provides top-of-the-line products with bariatric patients in mind. Its ReShapeOptimize supplement options, purchased through the ReShape Marketplace, include multivitamins, probiotics, calcium, vitamin D, protein, and other therapeutic offerings to optimize health.

Contact details

Address:
1001 CALLE AMANECER
SAN CLEMENTE
92673
United States
Telephone:
+1 (949) 4296680
Website:
https://www.reshapelifesciences.com/obalon/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
RSLS
ISIN:
US76090R2004
Market cap:
$4.27 million
Shares in issue:
23.46 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Dan Gladney
    Executive Chairman of the Board
  • Paul Hickey
    President, Chief Executive Officer, Director
  • Thomas Stankovich
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.